Respiratory Care Devices Market To See Record Break Revenue $21.30 billion By 2022 | Ventilators, Mask, PAP Devices, Inhalers, Pulse Oximeters

The use of respiratory care devices is expected to increase in the near future, owing to the spiraling rise in prevalence of chronic respiratory diseases, such as COPD and asthma. North America dominates the global respiratory care devices market, and is expected to maintain its lead throughout the forecast period, owing to the high adoption rate of respiratory devices

The global respiratory care devices market was valued at $12.89 billion in 2015, and is projected to reach $21.30 billion by 2022, registering a CAGR of 7.4% from 2016 to 2022.The therapeutic segment dominated the global market, accounting for more than half of the total market share in 2015.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1908

COVID-19 scenario-

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.

2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.

3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. These devices are majorly classified into therapeutic, diagnostic & monitoring devices, and consumables & accessories. These devices are used to deal with medical conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other acute & chronic respiratory diseases. Respiratory care devices are used in hospitals and homecare settings. The market for respiratory care devices have experienced a paradigm shift from stationary to portable devices. Increased adoption of portable devices has been a significant trend in the industry.

The global respiratory care devices market is driven by factors such as increase in prevalence of respiratory diseases, rapid urbanization, rise in pollution level, growth in geriatric population, and increase in tobacco consumption worldwide. In addition, governmental support has fueled the market growth. Moreover, high demand for therapeutic devices in homecare settings and increased healthcare spending are anticipated to provide lucrative opportunity for the market players. However, large pool of undiagnosed population and risks associated with certain therapeutic devices for neonates hamper for the growth of the respiratory care devices market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1908

The inhalers segment accounted for the major share in the respiratory care therapeutic devices market, and is expected to continue its dominance throughout the forecast period. This segment is expected to grow at a CAGR of 7.1% during 2016-2022, owing to high prevalence of respiratory diseases such as COPD and asthma among all age groups.

In 2015, North America accounted for nearly half of the global market, owing to the high prevalence of various respiratory diseases in the region. Europe holds the second position in the respiratory care devices market, accounting for two seventh share in 2015.

The Major Key Players Are:

Koninklijke Philips N.V., Hamilton Medical AG, Fisher & Paykel Healthcare Limited, ResMed, Inc., Invacare Corporation, Chart Industries Inc., Drger Safety AG & Co. KGaA, Becton, Dickinson and Company, Masimo Corporation, and Medtronic plc.

Access Full Report @ https://www.alliedmarketresearch.com/respiratory-care-devices-market

Key Findings of Respiratory Care Devices Market:

• The consumables and accessories segment is projected to grow at the fastest rate during the forecast period.
• North America held a dominant position in the regional landscape in 2015, occupying a share of nearly half of the total market.
• In 2015, the therapeutics segment accounted for a share of the more than half of the total respiratory care devices market.
• The monitoring and diagnostic devices segment collectively accounted for a share of one sixth of the global respiratory care devices market in 2015.

Similar Reports:

Polycystic Ovarian Syndrome Treatment Market : https://www.einpresswire.com/article/532259694/polycystic-ovarian-syndrome-treatment-market-value-to-hit-4-18-billion-by-2026-at-cagr-of-4-7-pcos

Cosmetic Laser Market : https://www.einpresswire.com/article/532261056/cosmetic-laser-market-size-on-target-to-growth-5-41-billion-by-2026

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.